Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POETIG trial of ponatinib in previously treated metastatic or unresectable GIST
2015-002285-23Phase 2Completed
- Sponsor
- Universitätsmedizin Essen
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ponatinib in gastrointestinal stromal tumor (GIST) (2 cohorts), sponsored by Universitätsmedizin Essen. Started Sep 2016; status: completed.
02
Drugs
ponatinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on 2015-002285-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002285-23.